InMode Ltd.
NASDAQ:INMDMedical - Devices
+$0.04 today
- Market cap
- $741.17M
- Beta
- 1.93
- P/E (TTM)
- 9.7
- EPS (TTM)
- $1.38
Volume 0.31M
Average 0.85M
INMD EBITDA Margin
EBITDA as a percentage of revenue.
InMode Ltd.NASDAQ: INMD
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin narrows to 17.7%
EBITDA Margin was 17.7% in Q1 FY2026, down 11.4 pp from a year earlier. On a trailing-twelve-month basis it was 27.5%, down 8.4 pp year over year. Over 3 fiscal years it narrowed by 14.5 pp.
Context
- EBITDA Margin widened in 0 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 4 analysts of 25.9% for the fiscal year ending Dec 2026, down from 30.0% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- 17.7%-12.6 pp QoQ
- Last fiscal yearDec 2025
- 30.0%-6.6 pp YoY
- LTMMar 2026
- 27.5%-8.4 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -11.4 pp | -9.5 pp | +1.9 pp |
| 1 year | -6.6 pp | -4.0 pp | +2.5 pp |
| 3 years | -14.5 pp | -6.3 pp | +8.2 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 30.0%
- Year-over-year change
- -6.6pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 30.0% | -6.6pp |
| FY2024 | 2024-12-31 | 36.5% | -7.8pp |
| FY2023 | 2023-12-31 | 44.3% | -0.2pp |
| FY2022 | 2022-12-31 | 44.5% | -2.6pp |
| FY2021 | 2021-12-31 | 47.1% | — |
EBITDA Margin vs competitors
How INMD compares with its peers on the latest reported figures
- INMD's LTM Mar 2026 EBITDA Margin of 27.5% is the highest of the 5 companies compared; the peer median is 8.9%.
- Its year-over-year change of -8.4 pp is the lowest of 5, against a peer median of +8.9 pp.
- Over three fiscal years its change of -14.5 pp compares with a peer median of -1.2 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 27.5% | -8.4 pp | -14.5 pp | |
| LTM Jun 2026 | 19.0% | -1.3 pp | -0.5 pp | |
| LTM Mar 2026 | 14.9% | +13.8 pp | -9.4 pp | |
| LTM Mar 2026 | 2.8% | +4.1 pp | -1.9 pp | |
| LTM Sep 2026 | -4.0% | +21.1 pp | +24.5 pp | |
| Peer median (excluding INMD) | 8.9% | +8.9 pp | -1.2 pp | |
Competitors are the stored peer set for INMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 357.57M | 454.27M | 492.05M | 394.82M | 370.5M |
| Cost of Revenue | 53.59M | 73.49M | 80.71M | 77.75M | 79.53M |
| Gross Profit | 303.97M | 380.79M | 411.34M | 317.07M | 290.97M |
| Gross Margin | 85.0% | 83.8% | 83.6% | 80.3% | 78.5% |
| Research & Development | 9.53M | 12.43M | 13.41M | 13.14M | 13.32M |
| Selling, General & Admin | 127.76M | 170.51M | 202.27M | 191.4M | 192.26M |
| Operating Expenses | 136.5M | 182.93M | 215.68M | 204.54M | 205.58M |
| Depreciation & Amortization | 517K | 680K | 623K | 728K | 695K |
| EBITDA | 168.52M | 202.15M | 217.89M | 144.2M | 111.03M |
| EBITDA Margin | 47.1% | 44.5% | 44.3% | 36.5% | 30.0% |
| Operating Income | 167.48M | 197.85M | 195.66M | 112.53M | 85.39M |
| Operating Margin | 46.8% | 43.6% | 39.8% | 28.5% | 23.0% |
| Interest Income | 525K | 3.61M | 21.61M | 30.94M | 24.94M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 525K | 3.61M | 21.61M | 30.94M | 24.94M |
| Income Before Tax | 168M | 201.47M | 217.27M | 143.47M | 110.33M |
| Pre-Tax Margin | 47.0% | 44.3% | 44.2% | 36.3% | 29.8% |
| Income Tax Expense | 2.93M | 39.95M | 19.35M | (37.81M) | 16.5M |
| Net Income | 164.97M | 161.52M | 197.92M | 181.28M | 93.83M |
| Net Margin | 46.1% | 35.6% | 40.2% | 45.9% | 25.3% |
| EPS (Basic) | 2.03 | 1.96 | 2.37 | 2.29 | 1.45 |
| EPS (Diluted) | 1.92 | 1.89 | 2.30 | 2.25 | 1.43 |
| Weighted Avg Shares | 81.44M | 82.48M | 83.53M | 79.31M | 64.63M |
| Weighted Avg Shares (Diluted) | 86.02M | 85.4M | 85.95M | 80.6M | 65.44M |
InMode Ltd.
NASDAQ:INMD
Intrinsic Alpha fair value
Locked
Current Price
$12.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.